论文部分内容阅读
目的:观察拉米夫定联合苦参素治疗慢性乙型肝炎的疗效。方法:将慢性乙型肝炎分为2组:治疗组服用拉米夫定联合苦参素,对照组单独服用拉米夫定,并观察肝功能情况和肝纤维化指标情况。结果:通过治疗,治疗组肝功能好转情况,HBeAg/抗HBe阴转率,肝纤维化好转情况均优于对照组。结论:苦参素与拉米夫定联合治疗可以促进肝功能恢复正常,明显提高抗病毒疗效,降低肝纤维化指标值。
Objective: To observe the efficacy of lamivudine combined with oxymatrine in the treatment of chronic hepatitis B. Methods: Chronic hepatitis B was divided into two groups: the treatment group took lamivudine combined with kushenin, the control group took lamivudine alone, and observed the liver function and liver fibrosis indicators. Results: Through the treatment, the treatment group improved liver function, HBeAg / anti-HBe negative conversion rate, improved liver fibrosis were better than the control group. Conclusion: Oxymatrine combined with lamivudine can promote normal liver function recovery, significantly improve the anti-viral efficacy and reduce the index value of liver fibrosis.